The global Computational Biology Market size is expected to
reach USD 13.6 billion by 2026, according to a new report by Grand View
Research, Inc. It is anticipated to expand at a CAGR of 21.3% during the
forecast period. Rise in clinical studies in pharmacokinetics and
pharmacogenomics for novel drug delivery and increase in the application of
computational biology for bioinformatics R&D programs for the population
based sequencing studies are fueling the market growth.
Rising use of computational tools in genomics,
epi-genomics, proteomics, and meta-genomics to understand 3D protein structural
analysis, protein-protein interactions, and gene sequencing and expression
studies coupled with increasing research activities in drug designing and
disease modeling is expected to drive the growth. However, lack of skilled
resources to operate computational tools is expected to restrain the growth of
the computational biology market during the forecast period.
Many pharmaceutical companies are seeking funding from
angel investors. For instance, in February 2019, StemoniX Inc., the U.S. based
provider of product and services for drug discovery and development, received
funding of USD 14.40 million from a group of investors. Brightstone Venture
Capital was the major financer and was later joined by Crescent Ridge Partners,
Alumni Ventures Group, and Mayo Clinic. Similarly, in the same month, U.S.
based Buffalo Niagara Medical Campus received funding of USD 5.0 million to
speed up the discovery of new drugs. With this finding, the research institute
is planning to procure and install drug discovery research instruments and
other drug discovery platforms.
Browse Details of Report @
https://www.grandviewresearch.com/industry-analysis/computational-biology-market
https://www.grandviewresearch.com/industry-analysis/computational-biology-market
Further key findings from the report
suggest:
- Cellular
and biological simulation is expected to expand at the fastest CAGR of
over 15.0% over the forecast period. The shift in sequencing studies
towards further analysis of the nature of various biological proteins as a
part of the development of personalized medicine, is projected drive the
growth
- Drug
discovery and disease modelling applications led the market, accounting
for 38.0% of the global market in terms of revenue in 2018. The factors
responsible for this growth are extensive drug pipelines for the global
drug manufacturing firms
- North
America was the largest regional market, accounted for more than 45.0% of
the global revenue in 2018. Increase in research activities for drug
discovery processes and innovations in biological computation tools are
anticipated to drive the growth
- Asia
Pacific is anticipated to witness the fastest of around CAGR of 23.0%
during the forecast period, due to increasing expenditure in the clinical
studies for the pharmaco-kinetics and pharmaco-genomics
- Some of
the players operating in the computational biology market include Chemical
Computing Group Inc.; Compugen Ltd.; Simulation Plus Inc.; Genedata AG;
Certara; Insilico Biotechnology AG; Accelrys; Rhenovia Pharma SAS;
Entelos; Nimbus Discovery LLC; and Rhenovia Pharma SAS.
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
Blog: https://healthcareforecastreport.blogspot.com/
No comments:
Post a Comment